Merck & Co., Inc. 13D and 13G filings for Harpoon Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-11 3:19 pm Sale | 2024-03-11 | 13D | Harpoon Therapeutics, Inc. HARP | MERCK SHARP & DOHME CORP. MRK | 1,000 100.000% | -3,079,815 (-99.97%) | Filing |
| 2024-01-17 5:48 pm Purchase | 2024-01-07 | 13D | Harpoon Therapeutics, Inc. HARP | MERCK SHARP & DOHME CORP. MRK | 3,080,815 17.480% | 3,080,815 (New Position) | Filing |